Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.

Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.

A hospital in Pittsburgh has become the latest medical center to join a ground-breaking Apple Watch trial in the US that's ...

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.

Medtronic (MDT) announced FDA approval ... treatment of persistent atrial fibrillation and for RF ablation of cavotricuspid isthmus dependent atrial flutter. With this approval, Medtronic is ...

The FDA has agreed on the use of AF monitoring devices in clinical trials for budiodarone approval ... and maintaining normal sinus rhythm. Atrial Fibrillation (AF) is the most common sustained ...

Atrial fibrillation, or AFib is the most common type of heart arrhythmia. A new type of procedure is helping get hearts back on beat.

Medtronic has announced that the US Food and Drug Administration (FDA) has approved the Affera mapping and ablation system featuring the Sphere-9 Catheter. This innovative, all-in-one system ...